Please login to the form below

early asset development

This page shows the latest early asset development news and features for those working in and with pharma, biotech and healthcare.

Redefining launch excellence in 2017

Now, more so than ever, launch preparation and commercial involvement should begin as early as possible in the asset’s development. ... It is crucial that these teams connect as early as possible, because whether it is intentional or not, the

Latest news

Cello Health expands with Defined Health acquisition

Defined Health will work closely with its new parent company in early asset development and commercialisation, with a particular focus on defining value for early-stage compounds. ... offer our clients through the full span of the development process

More from news
Approximately 0 fully matching, plus 2 partially matching documents found.

Latest Intelligence

Assessing early market opportunity

To successfully develop and launch an asset it’s crucial to identify and define the commercial value early in the process. ... On the 19. th. April Cello Health, in association with PMGroup, will host a free webinar which will discuss the background
Managing value: Why early asset development and commercialisation are important

Realising the full value of your asset - clinically and commercially - means thinking beyond the pure scientific value, even at the very early stages of development. ... Unsurprisingly, slightly more than half (approximately 8, 000) of those in
The value of early asset development and commercialisation

On July 13 Cello Health, in association with PMGroup, will host a free webinar on the value of early asset development and commercialisation. ... It will follow the asset development journey, defining value from both a financial and clinical perspective,

More from intelligence
Approximately 1 fully matching, plus 2 partially matching documents found.

Latest appointments

New faces at Merus, Rubius Therapeutics and Titan Pharmaceuticals

At Tmunity, she was responsible for the development of the company’s CAR-. ... This includes serving as executive director of oncology clinical development at Novartis, and asset team leader in early clinical development at Pfizer’s Oncology Business

More from appointments
Approximately 0 fully matching, plus 1 partially matching documents found.

Latest from PMHub

Managing value: Why early asset development and commercialization is important

Realising the full value of your asset – clinically and commercially – means thinking beyond the pure scientific value, even at the very early stages of development. ... There are many factors in that equation that either will increase or decrease

More from PMHub
Approximately 1 fully matching, plus 0 partially matching documents found.

COVID-19 Updates and Daily News

Featured jobs

PMHub

Add my company

Envision Pharma Group

We are a global leader in the medical affairs space. Our purpose-built software and scientific solutions make us a unique...

Latest intelligence

Surviving cancer: a new era for patients: Now more than ever, a shift in perspective is needed...
Crisis? No problem!: Issues planning & management for pharma spokespeople, by Andrew Smith...
Are patient recruitment and retention rates rising or falling?: First up, the good news. Over the past seven years, clinical trial recruitment rates have been on the rise....